United Kingdom· GB-APID-4642411000001100
Carboplatin 50mg/5ml solution for infusion vials
A carboplatin product containing carboplatin, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Carboplatin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01XA02 (carboplatin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Carboplatin · ATC L01XA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carboplatin costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.34 in Czechia to $7.73 in Switzerland — a ×23 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carboplatin · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$7.73
- CZ Czechia$0.34
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Carboplatin
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01XA02
- ATC class
- Carboplatin
- Defined daily dose
- 25 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5015997166610
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
564 interactions on record for carboplatin.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carboplatin · interactions on record
564 records
- 37 severe
- 205 moderate
- 15 minor
- 307 info
Most severe, free to view
- CidofovirJ05AB12severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- TopotecanL01CE01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Carboplatin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCarboplatinAccord Healthcare, Inc.
- BelgiumCarboplatin Accord Healthcare 10 mg/mlAccord Healthcare
- SwitzerlandCarboplatin Accord
- FinlandCarboloxJacobsen Pharma AS
- GermanyCarbo-CellStadapharm Gmbh
- CzechiaCARBOPLATIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- FranceCARBOPLATINE ACCORD 10 mg/ml, solution pour perfusionACCORD HEALTHCARE FRANCE
- SpainCARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Carboplatin Accord, Carboplatin Ebewe
- Belgium · Carboplatin Accord Healthcare, Carboplatin Eugia
- Bulgaria · Карбоплатин Ебеве
- Cyprus · Carboplatin Accord, Carboplatin Accord Healthcare
- Czechia · Carboplatin Accord, Carboplatin Kabi
- Germany · Carbo-Cell, Carbo-Cell®
- Denmark · Carbomedac, Carboplatin "ebewe"
- Estonia · Carboplatin Accord, Carboplatin Kabi
- Spain · Carboplatino Accord, Carboplatino Aurovitas
- Finland · Carboplatin Accord, Carboplatin Ebewe
- France · Carboplatine Accord, Carboplatine Arrow Lab
- Greece · Carboplan, Carboplatin Hospira
- Croatia · Karboplatin Accord, Karboplatin Pontus
- Hungary · Carboplatin Accord, Carboplatin Kabi
- Ireland · Carboplatin, Carboplatin Accord Healthcare Ireland
- Iceland · Carboplatin Actavis, Carboplatin Fresenius Kabi
- Italy · Carboplatino Ahcl, Carboplatino Aurobindo Italia
- Lithuania · Carboplatin Accord, Carboplatin Kabi
- Luxembourg · Carboplatine Fresenius Kabi, Carboplatine Onco-Tain Hospira
- Latvia · Carboplatin Accord, Carboplatin Ebewe
- Malta · Carboplan, Carboplatin Accord Healthcare
- Netherlands · Carboplatin Accord, Carboplatine Fresenius Kabi
- Norway · Carbomedac, Carboplatin Accord
- Poland · Carbomedac, Carboplatin Accord
- Portugal · Carboplatina Accord, Carboplatina Generis
- Romania · Carboplatin Actavis, Carboplatin Kabi
- Sweden · Carbomedac, Carboplatin Accord
- Slovenia · Carboplatin Ebewe, Karboplatin Accord
- Slovakia · Carbomedac, Carboplatin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb82ee95-cc46-46c0-8a43-e53d9b2c9f5c GET /v1/drugs/fb82ee95-cc46-46c0-8a43-e53d9b2c9f5c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4642411000001100",
"desc": "Carboplatin 50mg/5ml solution for infusion vials (Pfizer Ltd)",
"form": "Solution for infusion",
"vpid": "4651811000001109",
"source": "dmd",
"vtm_id": "775065009",
"strength": "10 mg",
"substance": "Carboplatin",
"ingredient": "Carboplatin",
"supplier_code": "2082201000001106"
}See everything about carboplatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.